INmune Bio shares are trading higher after the company announced it will host a webinar on cognitive testing using EMACC and CDR-SB on November 7 at 1 pm ET.
Portfolio Pulse from Benzinga Newsdesk
INmune Bio shares rose following the announcement of a webinar on cognitive testing using EMACC and CDR-SB, scheduled for November 7.
October 28, 2024 | 4:35 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
INmune Bio's stock price increased after announcing a webinar on cognitive testing, indicating positive investor sentiment.
The announcement of a webinar on cognitive testing suggests potential advancements or insights in INmune Bio's offerings, leading to increased investor interest and a rise in stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100